Invention Grant
- Patent Title: D2O stabilized pharmaceutical formulations
-
Application No.: US15578202Application Date: 2016-05-27
-
Publication No.: US11052094B2Publication Date: 2021-07-06
- Inventor: Gregory I. Ostrow , Kenneth J. Widder , David S. Baker
- Applicant: SYDNEXIS, INC.
- Applicant Address: US CA San Diego
- Assignee: SYDNEXIS, INC.
- Current Assignee: SYDNEXIS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2016/034823 WO 20160527
- International Announcement: WO2016/196367 WO 20161208
- Main IPC: A61K31/5575
- IPC: A61K31/5575 ; A61K47/02 ; A61K9/00 ; A61K9/08 ; A61K9/06 ; A61P27/02 ; A61K31/18 ; A61K31/216 ; A61K31/565 ; A61K31/57 ; A61K47/34 ; A61K47/38
Abstract:
Provided herein is an ophthalmic composition formulated in deuterated water. Also disclosed herein are methods of treating, ameliorating, or reducing ophthalmic conditions or diseases by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
Public/Granted literature
- US20180147214A1 D20 STABILIZED PHARMACEUTICAL FORMULATIONS Public/Granted day:2018-05-31
Information query
